Safflower Extract Mitigates MIRI in Rats by Modulating TLR-4/NF-κB Signaling Pathway, Demonstrating Protective

Mingling Deng1, Jing Yang1, Aimaiti Julaiti1

  • 1Second Department of Cadre Ward, Affiliated Hospital of Traditional Chinese Medicine of Xinjiang Medical University, No. 116, Huanghe Road, Urumqi, Xinjiang, 830000, China.

Abstract

Insights

Safflower extract protects the heart from ischemia-reperfusion injury by reducing inflammation. This study shows safflower extract effectively lowers infarct size and inflammatory markers by modulating the TLR-4/NF-κB pathway.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • Myocardial ischemia-reperfusion injury (MIRI) is a significant clinical challenge.
  • The Toll-like receptor 4 (TLR-4)/nuclear factor-kappa B (NF-κB) pathway is a key mediator of MIRI pathogenesis.

Purpose of the Study:

  • To investigate the cardioprotective effects of safflower extract against MIRI in a rat model.
  • To elucidate the impact of safflower extract on the TLR-4/NF-κB signaling pathway.

Main Methods:

  • Rats underwent 30 minutes of myocardial ischemia followed by 2 hours of reperfusion.
  • Safflower extract was administered intravenously at varying doses.
  • Infarct size, cardiac enzyme levels (CK, LDH), pro-inflammatory cytokines, and TLR-4/NF-κB expression were assessed.

Main Results:

  • Safflower extract significantly reduced infarct size and cardiac enzyme levels in a dose-dependent manner.
  • Treatment decreased levels of IL-1β, IL-6, and TNF-α, and downregulated TLR-4 and NF-κB expression.
  • Histological analysis revealed improved myocardial tissue structure and reduced inflammation.

Conclusions:

  • Safflower extract demonstrates significant cardioprotection against MIRI.
  • The cardioprotective effects are mediated through the modulation of the TLR-4/NF-κB inflammatory pathway.
  • Safflower extract holds potential as a therapeutic agent for MIRI.